"Triphala" - A New Herbal Mouthwash in Gingivitis
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
The present study was a randomized control clinical trial, which included 90 subjects with chronic generalised gingivitis of age group 25-40 years, reporting to outpatient department of Periodontics, Government Dental College \& Research Institute, Bangalore form January 2013 to April 2013. The research protocol was initially submitted and approved by the Institutional Ethical Committee and Review Board of the Government Dental College and Research Institute, Bangalore. After ethical approval, all subjects were verbally informed and written signed informed consent was taken for participation in the study. Ninety subjects diagnosed with chronic generalized gingivitis were randomly assigned into three groups: Group I: Placebo mouthwash, Group II: Triphala (TRP) mouthwash, Group III: Chlorhexidine (CHX) mouthwash. Subjects were instructed to use mouth wash twice daily. The plaque index (PI), gingival index (GI) and oral hygiene index- simplified (OHI-S) and microbiological colony counts were recorded on baseline (B/L) and 7, 30 and 60 days respectively. TRP mouthwash was found to decrease the inflammatory parameters. As improvement in gingivitis was comparable to that of CHX mouthwash thus TRP mouthwash can be considered as a potential therapeutic agent in treatment of gingivitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 3, 2013
CompletedFirst Posted
Study publicly available on registry
July 12, 2013
CompletedJuly 12, 2013
July 1, 2013
3 months
July 3, 2013
July 10, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Gingival Index (GI)
The primary outcome variable was the differences for the mean gingival Index (GI) from B/L to 7 days, 30 and 60 days.
differences for the mean GI from B/L to 7 days, 30 and 60 days
Secondary Outcomes (1)
Change in Plaque Index (PI)
From Baseline (B/L) to 7 days, 30 and 60 days
Other Outcomes (2)
Change in oral hygiene index simplified (OHI-S)
From baseline (B/L) to 7 days, 30 days and 60 days
Change in microbiological colony counts
From baseline (B/L) to 7 days, 30 days and 60 days
Interventions
Subjects were instructed to use 15ml mouthwash twice daily and were instructed not to rinse/eat anything for 30 min after mouthwash use. Subjects were also asked to refrain from all other unassigned forms of oral hygiene aids, including dental floss and chewing gum during the study. No oral hygiene instructions like brushing and flossing were given to the subjects to exclude the influence of improved oral hygiene practices on the results.
Subjects were instructed to use 15ml mouthwash twice daily and were instructed not to rinse/eat anything for 30 min after mouthwash use. Subjects were also asked to refrain from all other unassigned forms of oral hygiene aids, including dental floss and chewing gum during the study. No oral hygiene instructions like brushing and flossing were given to the subjects to exclude the influence of improved oral hygiene practices on the results.
Eligibility Criteria
You may qualify if:
- systemically healthy subjects of 25-40 years of age with previously untreated gingivitis and minimum 20 teeth,
- gingival index \> 1,
- pocket probing depth \< 3 mm,
- clinical attachment loss = 0,
- with no evidence of radiographic bone loss
You may not qualify if:
- use of systemic antibiotics and anti-inflammatory drugs in the previous 6 months,
- known systemic disease,
- with orthodontic appliances or bridge work that would interfere with evaluation,
- allergy to ingredient used in the study,
- alcoholics,
- who use tobacco in any form,
- mentally retarded subjects,
- pregnant or
- lactating females and
- subjects with poor compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 3, 2013
First Posted
July 12, 2013
Study Start
January 1, 2013
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
July 12, 2013
Record last verified: 2013-07